Exposure and Dosimetry Considerations for Adverse Outcome Pathways [article]

John Wambaugh, 0000-0002-4024-534X
2017
Presented at Adverse Outcome Pathways: From Research to Regulation
doi:10.23645/epacomptox.5082457 fatcat:uzddflbqpngxhemq7dg4rrawpu